OPKO Health Inc OPK

Healthcare Medical Care

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

NDAQ:OPK - Post by User

OPKO Health Inc

<< Previous

Bullboard Posts

Next >>

(242)
•••

Post by coolfooldumbguyon Jul 19, 2024 10:45am

142 Views

Post# 36139982

This pharmacist stock and biotech stock was

Bought by me at the beginning of this year.As usual for me,it was a boat load of shares :100000 shares at .90cents/share which was near its all time low of .85 cents per share and it's all time high was under $19.00 per share.It is run by a really old guy,like Joe Biden's age group,but really smart guy in his 80's age group : Dr. Charles somebody out of the state of Pennsylvania,and they are buying back shares now,but a really good company.My Target Price is $3.00 plus /share.

<< Previous

Bullboard Posts

Next >>

Baytex sells U.S. Eagle Ford assets for $3.25B, refocuses on Canadian growth